See more : Clara Resources Australia Ltd (C7A.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Moolec Science SA (MLEC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Moolec Science SA, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- The Tottori Bank, Ltd. (8383.T) Income Statement Analysis – Financial Results
- Ashland Inc. (ASH) Income Statement Analysis – Financial Results
- Bolt Metals Corp. (PCRCF) Income Statement Analysis – Financial Results
- Aurora Acquisition Corp. (AURC) Income Statement Analysis – Financial Results
- Logwin AG (TGHN.DE) Income Statement Analysis – Financial Results
Moolec Science SA (MLEC)
About Moolec Science SA
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 5.63M | 905.05K | 0.00 | 0.00 |
| Cost of Revenue | 5.15M | 1.05M | 0.00 | 0.00 |
| Gross Profit | 472.58K | -143.31K | 0.00 | 0.00 |
| Gross Profit Ratio | 8.40% | -15.83% | 0.00% | 0.00% |
| Research & Development | 1.77M | 1.35M | 985.16K | 0.00 |
| General & Administrative | 6.54M | 47.42M | 2.52M | 0.00 |
| Selling & Marketing | 643.06K | 256.42K | 105.06K | 0.00 |
| SG&A | 7.18M | 47.67M | 2.63M | 13.80K |
| Other Expenses | 564.22K | -42.51M | 0.00 | 0.00 |
| Operating Expenses | 9.52M | 6.51M | 3.65M | 13.80K |
| Cost & Expenses | 14.67M | 7.47M | 3.65M | 13.80K |
| Interest Income | 1.39M | 693.03K | 13.32K | 0.00 |
| Interest Expense | 1.17M | 160.04K | 2.13K | 0.00 |
| Depreciation & Amortization | 1.01M | 122.02K | 1.70K | 206.30K |
| EBITDA | -6.16M | -51.74M | -3.65M | -13.80K |
| EBITDA Ratio | -109.50% | -5,716.97% | 0.00% | 0.00% |
| Operating Income | -9.04M | -6.65M | -3.65M | -13.80K |
| Operating Income Ratio | -160.76% | -735.19% | 0.00% | 0.00% |
| Total Other Income/Expenses | 683.61K | -45.37M | -872.34K | -2.00 |
| Income Before Tax | -8.36M | -52.02M | -4.53M | -13.80K |
| Income Before Tax Ratio | -148.61% | -5,748.13% | 0.00% | 0.00% |
| Income Tax Expense | -1.05M | -234.54K | 2.13K | -206.30K |
| Net Income | -7.31M | -51.79M | -4.53M | -13.80K |
| Net Income Ratio | -129.99% | -5,722.22% | 0.00% | 0.00% |
| EPS | 0.00 | -1.50 | -0.26 | 0.00 |
| EPS Diluted | 0.00 | -1.50 | -0.26 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 34.47M | 17.37M | 17.37M |
| Weighted Avg Shares Out (Dil) | 0.00 | 34.47M | 17.37M | 17.37M |
Why Is Moolec Science (MLEC) Stock Up 121% Today?
Moolec Science (NASDAQ: MLEC ) stock is taking off on Monday after the company got approval from the Food and Drug Administration (FDA) for its plant-grown animal proteins. According to a press release from the company, this covers its genetically engineered...
Moolec Becomes First Molecular Farming Company to Achieve USDA Approval for Plant-Grown Animal Proteins
LUXEMBOURG / ACCESSWIRE / April 22, 2024 / Moolec Science SA (NASDAQ:MLEC)("The company"), a Molecular Farming food-ingredient company, announced today that the Animal and Plant Health Inspection Service ("APHIS") of the U.S. Department of Agriculture ("USDA") has concluded its Regulatory...
Moolec Science Presents Second Quarter Fiscal Year 2024 Business Update
LUXEMBOURG / ACCESSWIRE / March 13, 2024 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the second quarter of Fiscal Year...
Moolec Science to Host Second Quarter Fiscal Year 2024 Business Update Conference Call
LUXEMBOURG / ACCESSWIRE / March 6, 2024 / Moolec Science SA (NASDAQ:MLEC) ("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the...
Down -18.03% in 4 Weeks, Here's Why You Should You Buy the Dip in Moolec Science SA (MLEC)
Moolec Science SA (MLEC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal...
Why Is Moolec Science (MLEC) Stock Up 40% Today?
Moolec Science (NASDAQ: MLEC ) stock is getting a boost on Thursday despite a lack of news from the science-based food ingredient company. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why...
Moolec Science SA (MLEC) Q1 2024 Earnings Call Transcript
Moolec Science SA (NASDAQ:MLEC ) Q1 2024 Earnings Conference Call December 14, 2023 8:30 AM ET Company Participants Michael Bowen - ICR's, Strategic Communications and Advisory Gaston Paladini - CEO and Co-Founder Amit Dhingra - Chief Science Officer Jose Lopez...
Moolec Science Presents First Quarter Fiscal Year 2024 Business Update
LUXEMBOURG / ACCESSWIRE / December 14, 2023 / Moolec Science SA (NASDAQ:MLEC), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the first quarter of Fiscal Year...
Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call
LUXEMBOURG / ACCESSWIRE / December 7, 2023 / Moolec Science SA (NASDAQ:MLEC)("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the First...
Moolec Science Presents Fourth Quarter FY 2023 Business Update
LUXEMBOURG / ACCESSWIRE / October 20, 2023 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its Business Update for the fourth quarter of Fiscal Year 2023...
Source: https://incomestatements.info
Category: Stock Reports